REVUMENIB vs REZAFUNGIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REVUMENIB vs REZAFUNGIN: Safety Overview
| Metric | REVUMENIB | REZAFUNGIN |
|---|---|---|
| Total FAERS Reports | 371 | 108 |
| Deaths Reported | 49 | 12 |
| Death Rate | 13.2% | 11.1% |
| Hospitalizations | 93 | 20 |
| Average Patient Age | 46.4 yrs | 53.8 yrs |
| % Female Patients | 47.6% | 54.3% |
| FDA Approval Date | Nov 15, 2024 | Mar 22, 2023 |
| Manufacturer | Syndax Pharmaceuticals, Inc. | Melinta Therapeutics, LLC |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |